Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
Yale University
Yale University
University of Pittsburgh
M.D. Anderson Cancer Center
University of Pittsburgh
University of Wisconsin, Madison
Ruijin Hospital
University of Miami
Samsung Medical Center
M.D. Anderson Cancer Center